开发一种新型的中和单克隆抗体来对抗TrkB
Gamze Eda Yildirim1, Erkan Yilmaz1
1Biotechnology Institute, Ankara University, Ankara, Türkiye.
3 Biotech
|September 9, 2024
概括
针对TrkB受体的新单克隆抗体显示出显著的抗癌作用. TrkB-IgL 5.11抗体抑制癌细胞增殖并诱导细胞亡,为TrkB过度表达的癌症提供了一个有前途的治疗候选人.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- TrkB受体在人类癌症中高度表达,并作为一种亲瘤基因.
- 准TrkB是开发新型癌症疗法的战略.
研究的目的:
- 开发中和单克隆抗体 (mAbs) 针对TrkB受体的免疫球蛋白类 (Ig类) 域.
- 评估这些新型抗体的抗癌疗效.
主要方法:
- 再组合的TrkB-IgL被表达和净化.
- 给小鼠进行免疫,以产生产生抗TrkB-IgL抗体的混合瘤克隆.
- 通过细胞增殖试验 (xCELLigence) 和癌细胞系 (MCF-7,HCT116) 和SH-SY5Y细胞的西部涂抹测试来评估抗体的有效性.
主要成果:
- 四种混合瘤克隆 (TrkB-IgL 5.11, 4.11, 4.6, 4.3) 显示出对癌细胞的抗增殖作用.
- TrkB-IgL 5.11 和 4.11 mAbs显著抑制了TrkB介导的信号通路.
- TrkB-IgL 5.11 mAb 剂量依赖地抑制了 TrkB 酸化,Akt 和 ERK,同时诱导了 Caspase-3 和 Caspase-9 的活性.
结论:
- TrkB-IgL 5.11抗体通过抑制关键信号通路有效抑制癌细胞增殖并诱导细胞亡.
- 这种抗体是对过度表达TrkB的癌症的有希望的治疗候选者.
- TrkB-IgL 5.11抗体适用于人性化和癌症治疗中的潜在临床应用.
更多相关视频
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
7.7K
10:44A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants
Published on: August 9, 2019
7.2K
相关概念视频
Hybridoma Technology
14.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.1K
Enzyme-linked Receptors
77.6K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
77.6K
